Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Schreiber Alain
Relationship:   10% Owner
City:   Princeton
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   12,051,047    

Indirect Shares

   11,491,339      
Direct Value   $27,342,535    

Indirect Value

   $2,610,128      
Total Shares   23,542,386      
Total Value   $29,952,663      


Molecular Templates, Inc. $81,877 Palatin Technologies Inc $10,853,428 Cadence Pharmaceuticals Inc $0 Optimer Pharmaceuticals Inc $0 Immune Design Corp. $0 Urogen Pharma Ltd. $16,407,230 Molecular Templates, Inc. $81,877 Palatin Technologies Inc $10,853,428 Cadence Pharmaceuticals Inc $0 Optimer Pharmaceuticals Inc $0 Immune Design Corp. $0 Urogen Pharma Ltd. $16,407,230
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Molecular Templates, Inc. MTEM 10% Owner 2005-10-28 136,417 2005-10-28 3,385,203    Premium*  
            Palatin Technologies Inc PTN 10% Owner 2005-11-29 5,803,972 2005-11-29 0    Premium*  
            Cadence Pharmaceuticals Inc CADX Director, 10% Owner 2007-09-19 2,882,269 2006-10-30 12,500    Premium*  
            Optimer Pharmaceuticals Inc OPTR Director 2008-07-18 2,500 2009-03-04 811,998    Premium*  
            Avanir Pharmaceuticals AVNR 10% Owner 2008-08-06 0 2009-10-13 7,125,754    Premium*  
            Eagle Pharmaceuticals, Inc. EGRX 10% Owner 0 2017-05-15 155,884    Premium*  
            Immune Design Corp. IMDZ 10% Owner 2015-05-12 1,983,858 2015-03-05 0    Premium*  
            Urogen Pharma Ltd. URGN 10% Owner 2017-11-28 1,242,031 0    Premium*  
* Premium Members only  

Records found :    117         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
IMDZ Immune Design Corp. 10% Owner   –       –       •   2015-03-25 4 S $27.56 $136,587 D/D (4,956) 2,414,040 0 -
IMDZ Immune Design Corp. 10% Owner   –       –       •   2015-03-24 4 S $27.67 $365,244 D/D (13,200) 2,418,996 0 -
IMDZ Immune Design Corp. 10% Owner   –       –       •   2015-03-23 4 S $27.78 $138,900 D/D (5,000) 2,432,196 0 -
IMDZ Immune Design Corp. 10% Owner   –       –       •   2015-03-20 4 S $27.19 $257,974 D/D (9,464) 2,437,196 0 -
IMDZ Immune Design Corp. 10% Owner   –       –       •   2015-03-19 4 S $27.55 $826,604 D/D (30,000) 2,446,660 0 -
IMDZ Immune Design Corp. 10% Owner   –       –       •   2015-03-18 4 S $26.56 $531,509 D/D (20,000) 2,476,660 0 -
IMDZ Immune Design Corp. 10% Owner   –       –       •   2015-03-17 4 S $25.94 $518,800 D/D (20,000) 2,496,660 0 -
IMDZ Immune Design Corp. 10% Owner   –       –       •   2015-03-16 4 S $25.43 $262,158 D/D (10,309) 2,516,660 0 -
IMDZ Immune Design Corp. 10% Owner   –       –       •   2015-03-12 4 S $24.94 $2,349,323 D/D (94,199) 2,526,969 0 -
IMDZ Immune Design Corp. 10% Owner   –       –       •   2015-03-11 4 S $25.02 $725,580 D/D (29,000) 2,621,168 0 -
IMDZ Immune Design Corp. 10% Owner   –       –       •   2015-03-10 4 S $24.65 $151,425 D/D (6,143) 2,650,168 0 -
IMDZ Immune Design Corp. 10% Owner   –       –       •   2015-03-09 4 S $25.61 $827,203 D/D (32,300) 2,656,311 0 -
IMDZ Immune Design Corp. 10% Owner   –       –       •   2015-03-06 4 S $25.00 $28,652 D/D (1,146) 2,688,611 0 -
IMDZ Immune Design Corp. 10% Owner   –       –       •   2015-03-05 4 S $24.65 $147,900 D/D (6,000) 2,689,757 0 -
CADX Cadence Pharmaceuticals I... Director   –       •       •   2007-09-19 4 S $13.50 $1,032,727 D/D (74,300) 2,807,969 0 -
CADX Cadence Pharmaceuticals I... Director   –       •       •   2007-09-19 4 S $14.10 $409,919 D/D (28,800) 2,882,269 0 -
CADX Cadence Pharmaceuticals I... Director   –       •       •   2007-09-18 4 S $13.50 $106,650 D/D (7,900) 2,911,069 0 -
CADX Cadence Pharmaceuticals I... Director   –       •       •   2007-09-17 4 S $13.50 $2,700 D/D (200) 2,918,969 0 -
CADX Cadence Pharmaceuticals I... Director   –       •       •   2007-09-14 4 S $13.50 $6,750 D/D (500) 2,919,169 0 -
CADX Cadence Pharmaceuticals I... Director   –       •       •   2007-09-12 4 S $13.50 $33,940 D/D (2,500) 2,919,669 0 -
CADX Cadence Pharmaceuticals I... Director   –       •       •   2006-10-30 4 A $0.00 $0 D/D 3,053,174 3,053,174 0 -
MTEM Molecular Templates, Inc. 10% Owner   –       –       •   2005-10-28 4 S $10.46 $577,204 I/I (55,182) 3,385,203 -
MTEM Molecular Templates, Inc. 10% Owner   –       –       •   2005-02-04 3 IO $0.00 $0 D/D 0 3,440,205 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2017-04-03 4 S $83.13 $5,105,845 I/I (61,420) 3,584,087 0 -
EGRX Eagle Pharmaceuticals, In... 10% Owner   –       –       •   2017-03-31 4 S $83.02 $1,966,661 I/I (23,689) 3,645,507 0 -
  117  Records found
  1   2   3  4   5      
  Page 3 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us